| Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. |
2019-08-20 |
| Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. |
2019-08-20 |
| Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. |
2019-08-20 |
| Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. |
2019-08-19 |
| Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. |
2019-08-19 |
| Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. |
2019-08-19 |
| Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-08-16 |
| Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. |
2019-08-16 |
| iTeos Therapeutics S.A.. (8/13/19). "Press Release: iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer". Gosselies & Cambridge, MA. |
2019-08-13 |
| Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. |
2019-08-13 |
| Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. |
2019-08-13 |
| Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. |
2019-08-12 |
| 908 Devices, Inc.. (8/12/19). "Press Release: 908 Devices Launches the Rebel, the First At-line Spent Cell Media Analyzer for Bioprocess Labs". Boston, MA. |
2019-08-12 |
| Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. |
2019-08-12 |
| GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. |
2019-08-12 |
| Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. |
2019-08-12 |
| Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. |
2019-08-12 |
| High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". |
2019-08-08 |
| MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-08 |
| Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. |
2019-08-08 |
| BlueRock Therapeutics. (8/8/19). "Press Release: Bayer Acquires BlueRock Therapeutics to Build Leading Position in Cell Therapy". Berlin & Cambridge, MA. |
2019-08-08 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-07 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. |
2019-08-07 |
| Stemline Therapeutics, Inc.. (8/7/19). "Press Release: Stemline Therapeutics Announces Proposed Public Offering of Common Stock". New York, NY. |
2019-08-07 |
| Stemline Therapeutics, Inc.. (8/7/19). "Press Release: Stemline Therapeutics Announces Pricing of $76,250,000 Public Offering of Common Stock". New York, NY. |
2019-08-07 |
| Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY. |
2019-08-06 |
| ADC Therapeutics S.A.. (8/6/19). "Press Release: ADC Therapeutics and Sophia Genetics Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial". Lausanne. |
2019-08-06 |
| Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. |
2019-08-06 |
| NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE. |
2019-08-06 |
| BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv. |
2019-08-06 |
| Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. |
2019-08-06 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. |
2019-08-05 |
| Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. |
2019-08-05 |
| GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. |
2019-08-05 |
| Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA. |
2019-08-05 |
| Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. |
2019-08-05 |
| Roche. (8/5/19). "Press Release: Roche’s Tecentriq plus Platinum-based Chemotherapy Reduced the Risk of Disease Worsening or Death in People with Previously Untreated Advanced Bladder Cancer". Basel. |
2019-08-05 |
| ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". |
2019-08-02 |
| Thrive Earlier Detection Corporation. (8/1/19). "Press Release: Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer". Cambridge, MA. |
2019-08-01 |
| Bruker Corporation. (8/1/19). "Press Release: Bruker Reports Second Quarter 2019 Financial Results". Billerica, MA. |
2019-08-01 |
| Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update". Boston, MA. |
2019-08-01 |
| Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. |
2019-08-01 |
| Curetis N.V.. (8/1/19). "Press Release: Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-08-01 |
| Vida Ventures. (8/1/19). "Press Release: Vida Ventures Closes $600 Million Vida II Fund to Support Life Science Innovation". Boston, MA. |
2019-08-01 |
| Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. |
2019-08-01 |
| Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Appoints Dr. Maya Said to its Board of Directors". Boston, MA. |
2019-08-01 |
| Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. |
2019-07-31 |
| Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". |
2019-07-31 |
| Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. |
2019-07-31 |
| Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. |
2019-07-31 |
| Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon. |
2019-07-31 |
| Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund. |
2019-07-31 |
| AgroSavfe N.V.. (7/30/19). "Press Release: AgroSavfe Raises €35 million in Series C Financing". Ghent. |
2019-07-30 |
| Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. |
2019-07-29 |
| Exact Sciences Corporation. (7/29/19). "Press Release: Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company". Madison, WI & Redwood City, CA. |
2019-07-29 |
| Twist Bioscience Corporation. (7/25/19). "Press Release: Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA". San Francisco, CA. |
2019-07-25 |
| Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. |
2019-07-25 |
| Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. |
2019-07-25 |
| Fluidigm Corporation. (7/25/19). "Press Release: Bill W. Colston Named to Fluidigm Board of Directors". South San Francisco, CA. |
2019-07-25 |
| 908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. |
2019-07-25 |
| Qiagen N.V.. (7/24/19). "Press Release: Qiagen Reports Results for Second Quarter of 2019 – Updates Full-year 2019 Outlook Due to Decision to Restructure China NGS Partnership". Venlo. |
2019-07-24 |
| Freenome, Inc.. (7/24/19). "Press Release: Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. |
2019-07-24 |
| Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. |
2019-07-23 |
| Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. |
2019-07-22 |
| Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. |
2019-07-22 |
| Marker Therapeutics, Inc.. (7/20/19). "Press Release: Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR". San Francisco, CA. |
2019-07-20 |
| AvroBio, Inc.. (7/19/19). "Press Release: AvroBio Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridge, MA. |
2019-07-19 |
| Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. |
2019-07-19 |
| Genmab A/S. (7/19/19). "Press Release: Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering". Copenhagen. |
2019-07-19 |
| Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA. |
2019-07-19 |
| Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. |
2019-07-18 |
| ImCheck Therapeutics S.A.S.. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. |
2019-07-18 |
| Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. |
2019-07-18 |
| MyoKardia, Inc.. (7/18/19). "Press Release: MyoKardia Announces HCM Program Updates". South San Francisco, CA. |
2019-07-18 |
| Precision BioSciences Inc.. (7/18/19). "Press Release: Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States". Durham, NC. |
2019-07-18 |
| Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt. |
2019-07-18 |
| Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. |
2019-07-18 |
| Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. |
2019-07-18 |
| Merck KGaA. (7/18/19). "Press Release: Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation". Darmstadt. |
2019-07-18 |
| Bayer AG. (7/17/19). "Press Release: Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer". Leverkusen & Boston, MA. |
2019-07-17 |
| Bruker Corporation. (7/17/19). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. |
2019-07-17 |
| Immunic, Inc.. (7/16/19). "Press Release: Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer". San Diego, CA. |
2019-07-16 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. |
2019-07-16 |
| Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel. |
2019-07-16 |
| Evogene Ltd.. (7/16/19). "Press Release: Evogene Amends Its Collaboration Agreement with Bayer to Include Genome Editing Targets". Rehovot. |
2019-07-16 |
| Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. |
2019-07-15 |
| Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen. |
2019-07-14 |
| North Carolina Biotechnology Centre. (7/12/19). "Press Release: Raleigh to Host 2020 BIO World Congress on Industrial Biotechnology and Ag Tech". |
2019-07-12 |
| Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna. |
2019-07-11 |
| Agilent Technologies Inc.. (7/11/19). "Press Release: Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment". Santa Clara, CA. |
2019-07-11 |
| Novartis AG. (7/11/19). "Press Release: Novartis, Amgen and Banner Alzheimer's Institute Discontinue Clinical Program with BACE inhibitor CNP520 for Alzheimer's Prevention". Basel. |
2019-07-11 |
| Revolution Medicines, Inc.. (7/9/19). "Press Release: Revolution Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers". Redwood City, CA. |
2019-07-09 |
| ADC Therapeutics S.A.. (7/9/19). "Press Release: ADC Therapeutics Announces Final Close of Series E Financing Expansion". Lausanne. |
2019-07-09 |
| BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. |
2019-07-09 |
| Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. |
2019-07-09 |
| Celsius Therapeutics Inc.. (7/9/19). "Press Release: Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis". Cambridge, MA. |
2019-07-09 |
| Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. |
2019-07-08 |
| Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. |
2019-07-08 |
| Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. |
2019-07-08 |
| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date![[iito] Business Intelligence – The Elephants Are Coming 560x91px](/banner/iito-20190816-650-091-youtube-video-the-elephants-are-coming-telegram.jpg)
![Picture [iito] – Putting Information into Context 600x60px](/banner/iito-20181119-600-060-iito-business-intelligence-putting-information-into-context.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
